LifeVantage Corporation (Nasdaq: LFVN) a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023.
Fourth Quarter Fiscal 2023 Summary*:
Revenue of $54.2 million, an increase of 6.4% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was up approximately 7.8%;
Revenue in the Americas increased 17.9% including an 18.6% increase in the United States.
Revenue in Asia/Pacific & Europe decreased 16.0% and was down approximately 3.9% excluding the negative impact of foreign currency fluctuations;
Total active accounts declined 8.3% from the prior period to 143,000, reflecting a 3.8% decline in the Americas and a 18.0% decline in Asia/Pacific & Europe;
Net income per diluted share were $0.15, versus loss of $0.11 a year ago;
Adjusted earnings per diluted share were $0.17, compared to $0.01 a year ago; and
Adjusted EBITDA of $4.8 million, compared to $1.7 million a year ago.
* All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2023 to the fourth quarter of fiscal 2022, unless otherwise noted.
Fiscal Year 2023 Summary**:
Revenue increased 3.4% to $213.4 million. Excluding the negative impact of